Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3079% above fair value
$54.43−2.20 (-3.88%)
Close on Nov 20, 2026Market cap $4.87BP/E 39.2Yield –
Liquidia gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Liquidia's gross profit for the twelve months ending Mar 31, 2025 was $8.22M, down 33.0% year over year. For fiscal 2024 it was $8.12M, down 44.4% from the year before. The highest annual figure on record is $14.60M in fiscal 2023.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $8.12M | -44.4% |
| FY2023 | Dec 31, 2023 | $14.60M | +11.7% |
| FY2022 | Dec 31, 2022 | $13.08M | +33.0% |
| FY2021 | Dec 31, 2021 | $9.83M | +1858.5% |
| FY2020 | Dec 31, 2020 | $501.92K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | $1.60M | +6.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.56M | -55.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.88M | -7.2% |
| Q2 FY2024 | Jun 30, 2024 | $2.17M | -47.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.51M | -60.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.54M | -24.2% |
| Q3 FY2023 | Sep 30, 2023 | $3.11M | +28.2% |
| Q2 FY2023 | Jun 30, 2023 | $4.12M | +29.1% |
| Q1 FY2023 | Mar 31, 2023 | $3.84M | +37.2% |
| Q4 FY2022 | Dec 31, 2022 | $4.67M | +87.5% |
| Q3 FY2022 | Sep 30, 2022 | $2.43M | +5.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.19M | +19.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.80M | +17.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.49M | +395.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.29M | – |
| Q2 FY2021 | Jun 30, 2021 | $2.66M | – |
| Q1 FY2021 | Mar 31, 2021 | $2.39M | – |
| Q4 FY2020 | Dec 31, 2020 | $501.92K | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
See a number that looks wrong?